Age and Microvascular Function in Patients without Obstructive Coronary Artery Disease

At present, there is increasing interest in the microvascular function of patients with and without obstructive coronary artery disease of different ages. However, these “physiological” effects of age on microvascular function have never been directly quantified on patients without obstructive CAD. Prior studies have focused on patients with angina and obstructive CAD, and the effects on aging. 

Claves para mejorar la productividad en la sala de cateterismo

The aim of this prospective study was to quantitatively investigate the effect of age on microvascular function in patients with normal coronary arteries. 

In 314 patients with angina and no obstructive CAD (ANOCA), microvascular function was assessed using the continuous thermodilution method. In 305 patients, the link between age and both resting and hyperemic myocardial blood flow was assessed, looking at coronary flow reserve (CFR) and microvascular resistance reserve (MRR). Also, patients were divided into three groups according to age quartile (≤52 [24,9%], 53-64 [49,2%], and ≥65 years [25,9%]).

Read also: Invasive Correlation (CFR – IMR) with Coronary Slow Flow.

Mean patient age was 59, and they were mostly women. Mean resting coronary flow showed no significant difference between groups. There was a trend towards reduced mean hyperemic flow (Qmax) as age increased (p=0,083). Resistance increased significantly with age (p=0,005). In consequence, MRR decreased with age (3,2±1,2, 3,1±1,0, 2,9±0,9; p=0,038). This trend was present in patients with (n=121) and without (n=184) coronary microvascular dysfunction (CMD).

Conclusion

There is increased hyperemic microvascular resistance and reduced microvascular function depending on age. This reduction was present in patients with and without microvascular dysfunction, and was particularly apparent in patients without obstructive CAD, which emphasizes the fact that this phenomenon is independent of atherosclerosis. 

Dr. Andrés Rodríguez.
Member of the Editorial Board of SOLACI.org.

Original Title: Effects of age on microvascular function in patients with normal coronary arteries.

Reference: Tijn P.J. Jansen MD et al EuroIntervention 2024;20:e690-e698.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

DAPT ≤30 Days After Drug-Coated Balloon Coronary Angioplasty

Drug-coated balloon (DCB) coronary angioplasty without stent implantation has become a well-established alternative in several clinical scenarios, particularly in patients at high bleeding risk...

Is IVUS Always Necessary for Left Main Coronary Artery PCI?

Percutaneous coronary intervention (PCI) of the unprotected left main coronary artery is a highly complex procedure because of the large amount of myocardium at...

Dual-Prep Registry: Atherectomy and IVL for Severe Coronary Calcification

Severe coronary calcification remains one of the most challenging scenarios in percutaneous coronary intervention (PCI). Although rotational or orbital atherectomy and intravascular lithotripsy (IVL)...

Prehospital heparin in STEMI: A safe strategy associated with improved early reperfusion

Early reperfusion remains the main prognostic determinant in patients with ST-segment elevation myocardial infarction (STEMI). Although primary percutaneous coronary intervention (PCI) is the treatment...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

SAFE-PROTECT at 12 Months: AnchorMan vs. Watchman for Left Atrial Appendage Closure

Percutaneous left atrial appendage (LAA) closure is an alternative therapeutic strategy for reducing the risk of stroke in patients with atrial fibrillation (AF). Randomized...

Clinical and haemodynamic outcomes with contemporary intra- vs. supra-annular valves: The HERA-TAVI Registry

According to the latest European guidelines, transcatheter aortic valve implantation (TAVI) is the recommended treatment for patients aged ≥70 years with symptomatic severe aortic...

Redo-TAVI with SAPIEN 3: 30-Day Outcomes

The indications for transcatheter aortic valve implantation (TAVI) have rapidly expanded to include intermediate- and low-risk patients, extending its use to younger individuals with...